A. Cordier

947 total citations
30 papers, 713 citations indexed

About

A. Cordier is a scholar working on Molecular Biology, Physiology and Cancer Research. According to data from OpenAlex, A. Cordier has authored 30 papers receiving a total of 713 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Physiology and 6 papers in Cancer Research. Recurrent topics in A. Cordier's work include Carcinogens and Genotoxicity Assessment (6 papers), DNA Repair Mechanisms (4 papers) and Effects and risks of endocrine disrupting chemicals (3 papers). A. Cordier is often cited by papers focused on Carcinogens and Genotoxicity Assessment (6 papers), DNA Repair Mechanisms (4 papers) and Effects and risks of endocrine disrupting chemicals (3 papers). A. Cordier collaborates with scholars based in Switzerland, France and Belgium. A. Cordier's co-authors include C. Melción, Wilfried Frieauff, Armin Wolf, G. Sokal, J Rodhain, Jl. Michaux, A Ferrant, Herman Van den Berghe, Marc De Bruyère and M Moriau and has published in prestigious journals such as Blood, Biochemical Pharmacology and Life Sciences.

In The Last Decade

A. Cordier

29 papers receiving 660 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Cordier Switzerland 14 212 143 130 89 75 30 713
Frank K. Jugert Germany 18 467 2.2× 117 0.8× 36 0.3× 66 0.7× 202 2.7× 35 1.4k
Akiko Enomoto Japan 14 439 2.1× 98 0.7× 21 0.2× 52 0.6× 181 2.4× 28 937
Yoshinori Kasahara Japan 17 484 2.3× 285 2.0× 38 0.3× 87 1.0× 89 1.2× 37 1.1k
Philip Marder United States 17 418 2.0× 54 0.4× 51 0.4× 30 0.3× 265 3.5× 45 929
Margaret G. Kelly United States 12 233 1.1× 101 0.7× 26 0.2× 41 0.5× 53 0.7× 33 562
Wayne S. Stillman United States 19 335 1.6× 441 3.1× 155 1.2× 183 2.1× 227 3.0× 37 940
R. Bigley United States 20 374 1.8× 59 0.4× 45 0.3× 34 0.4× 99 1.3× 36 1.1k
Woon‐Won Jung South Korea 14 721 3.4× 112 0.8× 31 0.2× 25 0.3× 77 1.0× 34 1.1k
Michael S. Thibodeau United States 11 209 1.0× 62 0.4× 11 0.1× 57 0.6× 153 2.0× 26 870
Richard Sparla Germany 10 383 1.8× 236 1.7× 220 1.7× 16 0.2× 96 1.3× 21 925

Countries citing papers authored by A. Cordier

Since Specialization
Citations

This map shows the geographic impact of A. Cordier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Cordier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Cordier more than expected).

Fields of papers citing papers by A. Cordier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Cordier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Cordier. The network helps show where A. Cordier may publish in the future.

Co-authorship network of co-authors of A. Cordier

This figure shows the co-authorship network connecting the top 25 collaborators of A. Cordier. A scholar is included among the top collaborators of A. Cordier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Cordier. A. Cordier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Casile, Antonino, A. Cordier, Joseph R. Madsen, et al.. (2025). Neural correlates of minimal recognizable configurations in the human brain. Cell Reports. 44(3). 115429–115429.
2.
Dudal, Sherri, Thierry Flandre, Philip J. Lowe, et al.. (2015). Integrated pharmacokinetic, pharmacodynamic and immunogenicity profiling of an anti-CCL21 monoclonal antibody in cynomolgus monkeys. mAbs. 7(5). 829–837. 13 indexed citations
3.
Medina, J., et al.. (2000). Use of Human Skin Equivalent Apligraf for in Vitro Assessment of Cumulative Skin Irritation Potential of Topical Products. Toxicology and Applied Pharmacology. 164(1). 38–45. 18 indexed citations
4.
Bentley, P., et al.. (2000). The Industry View on Long‐Term Toxicology Testing in Drug Development of Human Pharmaceuticals. Pharmacology & Toxicology. 86(s1). 1–5. 9 indexed citations
5.
L’Azou, B., J. Medina, Wilfried Frieauff, et al.. (1999). In vitro models to study mechanisms involved in cyclosporine A-mediated glomerular contraction. Archives of Toxicology. 73(6). 337–345. 20 indexed citations
6.
Ulrich, Peter, et al.. (1999). Early changes in murine epidermal cell phenotype by contact sensitizers. Toxicological Sciences. 48(1). 74–81. 19 indexed citations
7.
Frieauff, Wilfried, et al.. (1998). Automatic analysis of the in vitro micronucleus test on V79 cells. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 413(1). 57–68. 31 indexed citations
8.
Fraissinette, Anne de Brugerolle de, Luis M. Cruz‐Orive, Max H. Schreier, et al.. (1998). Comparison of the phagocytosis of two types of cyclosporin (SDZ OXL 400 and SDZ IMM 125) by alveolar macrophages from hamsters. Cell Biology and Toxicology. 14(6). 411–418. 3 indexed citations
9.
Medina, J., A. Cordier, & Armin Wolf. (1997). Cyclosporine A -induced contraction of isolated rat aortic smooth muscle cells. Life Sciences. 61(22). PL327–PL332. 11 indexed citations
10.
Aicher, Lothar, et al.. (1997). Decrease in kidney calbindin-d 28kda as a possible mechanism mediating cyclosporine A- and FK-506-induced calciuria and tubular mineralization. Biochemical Pharmacology. 53(5). 723–731. 49 indexed citations
11.
Wolf, Armin, et al.. (1997). Enhancement of SDZ ICT 322-induced cataracts and skin changes in rats following vitamin E- and selenium-deficient diet. Archives of Toxicology. 71(5). 283–289. 9 indexed citations
12.
L’Azou, B., J. Medina, Wilfried Frieauff, A. Cordier, & Armin Wolf. (1996). 26 Mechanistic investigastions concerning the Cyclosporin A-induced impairment of glomerular function. Cell Biology and Toxicology. 12(4-6). 379–379. 1 indexed citations
13.
Melción, C., et al.. (1993). Lack of predictivity of bone marrow micronucleus test versus testis micronucleus test: comparison with four carcinogens. Mutation Research/Environmental Mutagenesis and Related Subjects. 292(2). 105–111. 28 indexed citations
14.
Melción, C., et al.. (1992). Carcinogen/ noncarcinogen in mouse hepatocyte micronucleus test. Mutation Research/Environmental Mutagenesis and Related Subjects. 271(2). 159–160. 1 indexed citations
15.
Depasse, François, et al.. (1992). Detection of micronuclei after exposure to mitomycin C, cyclophosphamide and diethylnitrosamine by the in vivo micronucleus test in mouse splenocytes. Mutation Research/Genetic Toxicology. 280(2). 137–142. 12 indexed citations
17.
Thybaud, V., et al.. (1991). Optimum associations of tester strains for maximum detection of mutagenic compounds in the Ames test. Mutation Research/Environmental Mutagenesis and Related Subjects. 252(3). 269–279. 11 indexed citations
18.
Vons, C., et al.. (1990). Comparison of cultured human hepatocytes isolated from surgical biopsies or cold-stored organ donor livers. Toxicology in Vitro. 4(4-5). 432–434. 12 indexed citations
19.
Fournier, E., et al.. (1989). In vivo micronucleus test using mouse hepatocytes. Mutation Research/Environmental Mutagenesis and Related Subjects. 216(6). 321–326. 47 indexed citations
20.
Melción, C., et al.. (1989). Limb bud cell culture for in vitro teratogen screening: Validation of an improved assessment method using 51 compounds. Teratogenesis Carcinogenesis and Mutagenesis. 9(2). 83–96. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026